All News
Checkpoint Inhibitor-related Myositis – Something Different
As expected, this year’s ACR meeting saw an upswing in the number of abstracts on immune related adverse events from checkpoint inhibitor therapy compared to last year.
Read ArticleSuleman Bhana, MD DrBhana ( View Tweet)
Emily Littlejohn ELittlejohnDO ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Dr. Erin Tree DrTinyTree ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Suleman Bhana, MD DrBhana ( View Tweet)
Simon Stones SimonRStones ( View Tweet)
Links:
Una Makris UnaMakris ( View Tweet)